TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $148,386 | -11.1% | 9,004 | -29.9% | 0.01% | 0.0% |
| Q3 2022 | $167,000 | -7.2% | 12,846 | -1.0% | 0.01% | 0.0% |
| Q2 2022 | $180,000 | -20.4% | 12,974 | -17.2% | 0.01% | 0.0% |
| Q1 2022 | $226,000 | -41.5% | 15,660 | -44.9% | 0.01% | -37.5% |
| Q4 2021 | $386,000 | -21.2% | 28,417 | -5.5% | 0.01% | -11.1% |
| Q3 2021 | $490,000 | +34.2% | 30,065 | +38.5% | 0.01% | +50.0% |
| Q2 2021 | $365,000 | -4.2% | 21,703 | +4.5% | 0.01% | -14.3% |
| Q1 2021 | $381,000 | +3.0% | 20,773 | +2.0% | 0.01% | -12.5% |
| Q4 2020 | $370,000 | +5.7% | 20,368 | +5.6% | 0.01% | -27.3% |
| Q3 2020 | $350,000 | +167.2% | 19,297 | +166.3% | 0.01% | +120.0% |
| Q2 2020 | $131,000 | – | 7,245 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 7,584,930 | $138,046,000 | 26.79% |
| Glenview Capital Management | 15,260,512 | $277,741,000 | 6.37% |
| Paulson & Co. | 11,295,846 | $205,584,000 | 5.34% |
| GMT CAPITAL CORP | 2,871,395 | $52,259,000 | 3.72% |
| MANAGED ASSET PORTFOLIOS, LLC | 966,643 | $17,593,000 | 3.09% |
| TFG Asset Management GP Ltd | 1,443,052 | $26,264,000 | 1.76% |
| Mondrian Investment Partners LTD | 3,274,660 | $58,944,000 | 1.46% |
| Blackcrane Capital, LLC | 35,236 | $641,000 | 1.26% |
| Lumbard & Kellner, LLC | 136,378 | $2,404,000 | 0.95% |
| DAVIDSON INVESTMENT ADVISORS | 509,800 | $9,278,000 | 0.86% |